Starling Oncology, Inc.
Returns on Capital
| Period | ROE | ROI | ROA |
|---|---|---|---|
| Mar 2020 | 4.7% | 4.7% | -0.3% |
| Jun 2020 | 13.7% | 13.7% | -1.1% |
| Sep 2020 | 11.2% | 11.2% | -1.0% |
| Mar 2021 | -2.1% | -2.1% | -0.4% |
| Jun 2021 | 6.4% | 6.4% | 1.4% |
| Sep 2021 | -6.3% | -6.3% | -1.3% |
| Mar 2022 | 14.6% | 14.6% | 9.3% |
| Jun 2022 | -4.4% | -4.4% | -2.9% |
| Sep 2022 | -2.1% | -1.3% | -0.9% |
| Mar 2023 | -30.5% | -16.6% | -12.8% |
| Jun 2023 | -19.9% | -10.0% | -7.3% |
| Sep 2023 | -24.2% | -11.1% | -8.0% |
| Mar 2024 | -48.2% | -15.3% | -9.7% |
| Jun 2024 | -53.0% | -13.0% | -8.6% |
| Sep 2024 | -104.1% | -15.1% | -9.0% |
| Mar 2025 | -386.4% | -24.8% | -11.9% |
| Jun 2025 | 189.3% | -25.8% | -10.6% |
| Sep 2025 | 134.5% | -25.8% | -10.1% |
| Mar 2026 | 15.3% | -4.0% | -1.5% |
| Jun 2026 | 39.3% | -17.8% | -5.5% |